P084 Clinical response to Ustekinumab in Crohn’s disease is linked to a dose-dependent reduction of T follicular helper cells

Autor:	Christoph M. Schempp, N P Sommer, Anne K. Thomann, R Schreiner, Robert Thimme, Maike Hofmann, W Reindl, AM Globig, Peter Hasselblatt
Rok vydání:	2019
Předmět:	Crohn's disease business.industry medicine.medical_treatment Gastroenterology Dose dependence General Medicine medicine.disease Follicular phase Immunology Ustekinumab medicine business Reduction (orthopedic surgery) medicine.drug
Zdroj:	Journal of Crohn's and Colitis. 13:S127-S127
ISSN:	1876-4479 1873-9946
DOI:	10.1093/ecco-jcc/jjy222.208
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d44cd488847f6c4b95ea23df0ead570b https://doi.org/10.1093/ecco-jcc/jjy222.208 Zobrazit plný text záznamu